Luciferase-tagged Glioma Stem Cell Model: A Lentivirus-mediated Method to Prepare Luciferase-tagged Glioma Stem Cells for In Vitro Therapeutic Studies

Published: April 30, 2023

Abstract

Source: Hu, Z. et al. A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells. J. Vis. Exp. (2021)

This video demonstrates the establishment of luciferase-tagged glioma stem cells via lentivirus-mediated gene delivery. Luciferase acts as a reporter gene and helps facilitate rapid drug screening experiments.

Protocol

1. Preparing Luciferase-tagged GSCs Begin with the GSCs culture and centrifuge at 70 x g for 3 min at room temperature. Remove the supernatant and digest the cells with accutase for 4 min at 37 °C. Use a 200 µL tip and pipette repeatedly to dissociate and resuspend the cell pellet. Dilute the cells to 2 x 105 cells per well in a 12-well culture plate and culture the cells overnight. Add 30 µL luciferase-EGFP virus…

Offenlegungen

The authors have nothing to disclose.

Materials

B-27 Gibco 17504-044 50X
EGF Gibco PHG0313 20 ng/ml
FGF Gibco PHG0263 20 ng/ml
Gluta Max Gibco 35050061 100X
Neurobasal Gibco 21103049 1X
Penicillin-Streptomycin HyClone SV30010 P: 10,000 units/ml     S:  10,000 ug/ml
Sodium Pyruvate Gibco 2088876 100 mM

Tags

Play Video

Diesen Artikel zitieren
Luciferase-tagged Glioma Stem Cell Model: A Lentivirus-mediated Method to Prepare Luciferase-tagged Glioma Stem Cells for In Vitro Therapeutic Studies. J. Vis. Exp. (Pending Publication), e20613, doi: (2023).

View Video